Global Positron Emission Tomography (PET) Scanners Market Strategic Research Report

Scope of the Report

The global Positron Emission Tomography (PET) Scanners market size is predicted to grow from US$ 838 million in 2025 to US$ 1,139 million in 2032; it is expected to grow at a CAGR of 4.6% from 2026 to 2032.

Positron emission tomography scanners are advanced medical imaging systems that use positron-emitting radiotracers to visualize molecular and functional processes within the human body. After a tracer participates in metabolic, receptor-binding or perfusion pathways, emitted positrons annihilate with electrons and generate pairs of photons that are detected simultaneously by the scanner. Computer reconstruction then produces three-dimensional images reflecting tissue physiology and molecular activity. Major product forms include standalone PET, PET/CT combining functional and anatomical information, and PET/MR integrating molecular imaging with superior soft-tissue characterization. A typical system consists of scintillation-crystal detectors, photodetectors, data-acquisition electronics, a gantry, patient table, reconstruction software and a CT or MR subsystem. Principal applications include oncology diagnosis and staging, treatment-response assessment, neurology, cardiology and radiopharmaceutical theranostics.In 2025, global Positron Emission Tomography (PET) Scanners production reached approximately 980 units.

Population aging and the expanding clinical burden of cancer, neurodegenerative disorders and cardiovascular diseases are shifting medical imaging from anatomical observation toward the assessment of cellular metabolism, receptor expression and disease mechanisms. The development of precision medicine and theranostics is strengthening the strategic role of PET in patient selection, treatment planning, response monitoring and recurrence evaluation. Total-body and long-axial-field-of-view PET, digital detectors, AI-enabled reconstruction and automated quantification are also reducing scan times and injected doses while improving system throughput. In China, large medical-equipment configuration planning, tiered healthcare development and equipment-renewal programs are creating additional opportunities for regional nuclear-medicine centers and advanced hospitals.

PET scanners involve high acquisition costs, long project-development cycles and complex supporting infrastructure. Healthcare institutions must obtain applicable equipment-configuration approvals and establish nuclear-medicine operations that meet radiation-protection, room-environment, performance-testing and continuous quality-control requirements. Because many positron-emitting radiopharmaceuticals have short half-lives, scanner utilization depends heavily on cyclotrons, radiopharmacy centers and reliable regional distribution networks. Limited tracer availability can restrict operational efficiency outside major medical hubs. The market also faces shortages of nuclear-medicine physicians, medical physicists and technologists, reimbursement and examination-pricing pressure, and supply risks involving advanced detectors, electronic components and critical software.

Procurement demand is evolving from basic access to PET examinations toward higher sensitivity, faster acquisition, lower-dose imaging, accurate quantification and broader disease coverage. Oncology remains the principal application, while myocardial-perfusion, neurological receptor and brain-metabolism imaging are expanding demand from cardiology and neurology. Theranostics is also integrating PET more closely with radiopharmaceutical selection, dosimetry and treatment follow-up. Large hospital networks increasingly prioritize standardized protocols, remote interpretation, intelligent quality control and utilization management, while academic institutions favor long-axial-field-of-view systems, dynamic whole-body imaging and multi-tracer research capabilities. These trends are transforming the market from conventional equipment procurement into integrated clinical, research and digital-imaging platforms.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Positron Emission Tomography (PET) Scanners market?

What factors are driving Positron Emission Tomography (PET) Scanners market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Positron Emission Tomography (PET) Scanners market opportunities vary by end market size?

How does Positron Emission Tomography (PET) Scanners break out by Type, by Application?

This report presents a comprehensive overview of the global Positron Emission Tomography (PET) Scanners market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• PET/CT Scanner
• PET/MRI Scanner
• Other

Segment by Detector Technology

• LSO/LYSO Detector
• Digital SiPM Detector
• Analog PMT Detector
• Other

Segment by Application

• Hospitals
• Diagnostic Centers
• Research Centers

Segment by Application

• Oncology
• Neurology
• Cardiology
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Positron Emission Tomography (PET) Scanners market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Oncology, Neurology, Cardiology evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact